Von der opportunistischen PSA-Testung zur individualisierten, risikobasierten Früherkennung des Prostatakarzinoms in Deutschland
Christian Gilfrich(Barmherzige Brüder Klinikum St. Elisabeth in Straubing), Stefan Siepmann(Barmherzige Brüder Klinikum St. Elisabeth in Straubing), Ingmar Wolff(Universitätsmedizin Greifswald), Maximilian Haas(University of Freiburg), Kay-Patrick Braun(Otto-von-Guericke-Universität Magdeburg), Maximilian Burger(University of Regensburg), Matthias May(Barmherzige Brüder Klinikum St. Elisabeth in Straubing), Steffen Lebentrau(Medizinische Hochschule Brandenburg Theodor Fontane)
Cited by 0
Related Papers
The Effect of Exercise Training Programs on Bone Mass: A Meta-analysis of Published Controlled Trials in Pre- and Postmenopausal Women
|Osteoporosis International|1999|594
Prediction of 90-day Mortality After Radical Cystectomy for Bladder Cancer in a Prospective European Multicenter Cohort
|European Urology|2014|206
Prediction of Progression of Non–Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study
|European Urology|2008|178